Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02241408Unknown

Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis

Role: lead

NCT02348060Unknown

Outcomes Data of Adipose Stem Cells to Treat Chronic Obstructive Pulmonary Disease

Role: lead

NCT02184546Unknown

Outcomes Data of Adipose Stem Cells to Treat Parkinson's Disease

Role: lead

NCT02157064Unknown

Outcomes Data of Adipose Stem Cells to Treat Multiple Sclerosis

Role: lead

NCT02348086Unknown

Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis

Role: lead

All 5 trials loaded